financetom
Business
financetom
/
Business
/
Madrigal Pharmaceuticals Insider Sold Shares Worth $8,214,998, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Madrigal Pharmaceuticals Insider Sold Shares Worth $8,214,998, According to a Recent SEC Filing
Apr 4, 2024 7:25 AM

10:07 AM EDT, 04/04/2024 (MT Newswires) -- Kenneth Bate, Director, on April 01, 2024, sold 32,489 shares in Madrigal Pharmaceuticals ( MDGL ) for $8,214,998. Following the Form 4 filing with the SEC, Bate has control over a total of 1,198 shares of the company, with 1,198 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1157601/000089924324000245/xslF345X03/doc4.xml

Price: 245.96, Change: +0.73, Percent Change: +0.30

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Set to Exceed Fiscal Q3 Outlook Amid Sustained AI Momentum, UBS Says
Nvidia Set to Exceed Fiscal Q3 Outlook Amid Sustained AI Momentum, UBS Says
Nov 10, 2025
11:50 AM EST, 11/10/2025 (MT Newswires) -- Nvidia's ( NVDA ) fiscal Q3 results are set to exceed the company's guidance, reflecting steady momentum from its artificial intelligence and data center graphics processing unit, or GPU, business, UBS said in a note Sunday. The chipmaker is scheduled to release its fiscal Q3 2026 results following the market close on Nov....
Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029
Galecto Stock Soars: Strengthens Blood Cancer Pipeline With Damora Therapeutics Deal, Secures Fresh Funding To 2029
Nov 10, 2025
Galecto Inc ( GLTO ). stock tripled on Monday, with a session volume of 23.26 million, compared to the average volume of 2.41 million, as per data from Benzinga Pro. Galecto ( GLTO ) acquired Damora Therapeutics, Inc., a privately held biotechnology company advancing a pipeline of antibody therapeutics for mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms, including essential thrombocythemia and myelofibrosis....
Xtract One Technologies Raises $11.5 Million in a Bought-Deal Public Offering of Share Units
Xtract One Technologies Raises $11.5 Million in a Bought-Deal Public Offering of Share Units
Nov 10, 2025
11:51 AM EST, 11/10/2025 (MT Newswires) -- Xtract One Technologies ( XTRAF ) on Monday closed a bought-deal public offering of share units that raised $11.5 million including the full exercise of the underwriters over-allotment option. The company sold underwriters 15.3-million units at $0.75 each an made up of a share and one-half of a three-year warrant to buy a...
DigitalOcean Showing Better Traction, Momentum With Customers, Oppenheimer Says
DigitalOcean Showing Better Traction, Momentum With Customers, Oppenheimer Says
Nov 10, 2025
11:49 AM EST, 11/10/2025 (MT Newswires) -- DigitalOcean ( DOCN ) is showing improving traction and momentum with existing and new customers as part of a broader turnaround story, Oppenheimer said in a Monday note. Customers are expected to expand their usage of DigitalOcean's ( DOCN ) infrastructure-as-a-service and platform-as-a-service cloud offerings, particularly for AI inferencing workloads. Oppenheimer said the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved